Range Low Price High Price Comment
30 days $12.65 $19.34 Thursday, 28th Mar 2024 VERV stock ended at $13.28. This is 0.682% more than the trading day before Wednesday, 27th Mar 2024. During the day the stock fluctuated 5.17% from a day low at $12.96 to a day high of $13.63.
90 days $10.31 $19.34
52 weeks $8.22 $21.42

Historical Verve Therapeutics, Inc. prices

Date Open High Low Close Volume
2024-03-28 $13.28 $13.63 $12.96 $13.28 630 174
2024-03-27 $12.98 $13.24 $12.65 $13.19 633 399
2024-03-26 $13.28 $13.43 $12.77 $12.79 663 820
2024-03-25 $13.04 $13.23 $12.81 $13.16 507 525
2024-03-22 $13.21 $13.24 $12.83 $12.97 557 514
2024-03-21 $13.61 $14.26 $13.05 $13.21 857 321
2024-03-20 $12.95 $13.54 $12.67 $13.38 755 301
2024-03-19 $13.10 $13.48 $12.89 $13.01 858 050
2024-03-18 $13.84 $13.84 $12.82 $13.31 835 021
2024-03-15 $13.54 $14.03 $13.47 $13.81 3 728 372
2024-03-14 $14.18 $14.18 $13.39 $13.60 958 057
2024-03-13 $13.85 $14.51 $13.85 $14.34 949 651
2024-03-12 $14.57 $14.57 $13.60 $13.92 1 068 532
2024-03-11 $14.99 $15.55 $14.23 $14.42 877 138
2024-03-08 $15.37 $16.03 $14.73 $14.96 636 079
2024-03-07 $15.21 $15.81 $14.91 $14.94 936 900
2024-03-06 $15.42 $15.62 $14.92 $15.07 1 184 729
2024-03-05 $15.66 $16.05 $14.84 $15.14 1 102 533
2024-03-04 $16.40 $16.43 $15.37 $15.84 1 312 349
2024-03-01 $17.07 $17.33 $16.15 $16.29 1 792 620
2024-02-29 $18.96 $19.34 $16.89 $17.05 1 880 640
2024-02-28 $16.57 $18.95 $16.56 $17.96 2 149 919
2024-02-27 $15.29 $17.73 $15.00 $17.54 2 393 804
2024-02-26 $13.28 $14.53 $13.23 $14.44 1 033 727
2024-02-23 $13.25 $13.56 $13.20 $13.45 546 344
Click to get the best stock tips daily for free!

About Verve Therapeutics, Inc.

Verve Therapeutics. Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program to permanently turn off the ANGPTL3 gene in the liver. It has a collaboration and license agreement with... VERV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT